Home › Companies › LifeStance Health Group, Inc. › 2025-2026

LifeStance Health Group, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and LifeStance Health Group, Inc.’s Form 8-K, filed June 4, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 4Ballot items
  • 214Asset managers
  • 1,175Fund votes
  • June 2, 2026Meeting date

Results at a glance

Meeting of June 2, 2026: 4 items on LifeStance Health Group, Inc.’s Form 8-K, filed June 4, 2026: 2 elected · 2 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore LifeStance Health Group, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by LifeStance Health Group, Inc.

These tallies are LifeStance Health Group, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

LifeStance Health Group, Inc. — official shareholder meeting results, meeting held June 2, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: David Bourdon 244,968,319---- 83,966,05229,782,714 74%Elected—
Elect Director: Robert Bessler 280,015,618---- 48,918,75329,782,714 85%Elected—
2. Ratification of the Company's Independent Registered Public Accounting Firm 357,756,707209,431750,947 ---- 99.9%Approved—
3. Advisory Vote on Named Executive Officer Compensation 322,904,3595,675,861354,151 --29,782,714 98%Approved—

Source: LifeStance Health Group, Inc., Form 8-K, filed with the SEC on June 4, 2026 — read the filing on EDGAR.

How asset managers voted at the LifeStance Health Group, Inc. 2025-2026 meeting

Each item below shows how the 214 asset managers that disclosed a LifeStance Health Group, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: David Bourdon

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD
FOR: 244,968,319WITHHELD: 83,966,052
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: David Bourdon

LifeStance Health Group, Inc.’s own tally for this item (“Elect Director: David Bourdon”): 244,968,319 for, 83,966,052 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company's Board of Directors as members of Class II for a term of three years.”
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 40,630,974 for, 61,965,042 withheld, 261 abstained.

FORWITHHOLD
FOR: 40,630,974ABSTAIN: 261WITHHOLD: 61,965,042
Largest asset managers voting on “Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stock” at LifeStance Health Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity4,357,3660 052,653,118Mixed
Vanguard17,528,3350 2610For
BlackRock7,390,8800 00For
Prudential/PGIM4,846,6540 033,203For
Dimensional00 03,763,194Withhold
TIAA2,179,2450 00For
Charles Schwab1,543,5080 00For
FIRST EAGLE FUNDS00 01,400,785Withhold
Principal00 01,159,930Withhold
Putnam00 0828,900Withhold
First Trust00 0792,977Withhold
Equitable368,7520 00For
Goldman Sachs345,2380 00For
State Street303,9630 0676For
QUANTITATIVE MASTER SERIES LLC267,9570 00For
Northern Lights Fund Trust IV254,3650 00For
Loomis Sayles00 0239,615Withhold
MERIDIAN FUND INC215,0380 00For
Mercer Funds00 0193,729Withhold
Principal Exchange-Traded Funds00 0191,892Withhold
Lincoln Financial96,7000 080,255Mixed
Northern Trust141,6310 00For
Global X112,5450 00For
MASTER INVESTMENT PORTFOLIO112,2660 00For
Invesco110,0310 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

2. Elect Director: Robert Bessler

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD
FOR: 280,015,618WITHHELD: 48,918,753
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Robert Bessler, M.D.

LifeStance Health Group, Inc.’s own tally for this item (“Elect Director: Robert Bessler”): 280,015,618 for, 48,918,753 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company's Board of Directors as members of Class II for a term of three years.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 82,447,738 for, 20,148,442 withheld, 98 abstained.

FORWITHHOLD
FOR: 82,447,738ABSTAIN: 98WITHHOLD: 20,148,442
Largest asset managers voting on “Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stock” at LifeStance Health Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity56,731,8750 0278,609For
Vanguard17,511,0920 9817,406For
BlackRock00 07,390,880Withhold
Prudential/PGIM4,846,6540 033,203For
Dimensional00 03,763,194Withhold
TIAA00 02,179,245Withhold
Charles Schwab1,543,5080 00For
FIRST EAGLE FUNDS00 01,400,785Withhold
Principal00 01,159,930Withhold
Putnam00 0828,900Withhold
First Trust00 0792,977Withhold
Equitable00 0368,752Withhold
Goldman Sachs345,2380 00For
State Street2570 0304,382Withhold
QUANTITATIVE MASTER SERIES LLC00 0267,957Withhold
Northern Lights Fund Trust IV254,3650 00For
Loomis Sayles239,6150 00For
MERIDIAN FUND INC215,0380 00For
Mercer Funds193,7290 00For
Principal Exchange-Traded Funds00 0191,892Withhold
Lincoln Financial00 0176,955Withhold
Northern Trust00 0141,631Withhold
Global X112,5450 00For
MASTER INVESTMENT PORTFOLIO00 0112,266Withhold
Invesco110,0310 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

3. 3. Advisory Vote on Named Executive Officer Compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 322,904,359AGAINST: 5,675,861
Details: description as filed, official tally, votes by 214 asset managers

Description as filed by funds: Approval, on an advisory basis, of the compensation of the Company's named executive officers;

LifeStance Health Group, Inc.’s own tally for this item (“3. Advisory Vote on Named Executive Officer Compensation”): 322,904,359 for, 5,675,861 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, the Company's named executive officer compensation.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 62 asset managers voting on “Approval, on an advisory basis, of the compensation of the Company's named executive officers;” at LifeStance Health Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity57,010,4840 00For
Vanguard17,528,57916 10For
BlackRock7,390,8800 00For
Prudential/PGIM4,879,8570 00For
Dimensional3,763,1940 00For
TIAA2,179,2450 00For
Charles Schwab1,543,5080 00For
FIRST EAGLE FUNDS1,400,7850 00For
Principal1,159,9300 00For
Putnam828,9000 00For
First Trust792,9770 00For
Equitable368,7520 00For
Goldman Sachs345,2380 00For
State Street304,125514 00For
QUANTITATIVE MASTER SERIES LLC267,9570 00For
Northern Lights Fund Trust IV254,3650 00For
Loomis Sayles239,6150 00For
MERIDIAN FUND INC215,0380 00For
Mercer Funds193,7290 00For
Principal Exchange-Traded Funds191,8920 00For
Lincoln Financial176,9550 00For
Northern Trust141,6310 00For
Global X112,5450 00For
MASTER INVESTMENT PORTFOLIO112,2660 00For
Invesco0110,031 00Against

Fund voting reports, all 62 managers: 102,445,305 for, 149,785 against, 1 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 170 asset managers voting on “Approval, on an advisory basis, of the compensation of the Company's named executive officers;” at LifeStance Health Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity58,390,4150 00For
JENNISON ASSOCIATES LLC9,763,36753,328 00For
BlackRock7,852,05368,574 00For
GEODE CAPITAL MANAGEMENT, LLC4,730,9010 00For
State Street3,473,492270 00For
UBS02,595,011 00Against
Integral Health Asset Management, LLC2,445,9520 00For
Nuveen2,210,9320 00For
PRINCIPAL GLOBAL INVESTORS1,936,7020 00For
Woodline Partners LP1,775,0530 00For
Loomis Sayles1,646,7090 00For
First Eagle Investment Management, LLC1,610,4660 00For
Vanguard1,571,0570 00For
Charles Schwab1,544,9680 00For
Northern Trust1,308,3480 00For
Dimensional1,159,5920 00For
Putnam829,1880 00For
Goldman Sachs792,8440 00For
SEI720,5810 00For
AQR657,6370 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.621,2850 00For
Prudential/PGIM608,4550 00For
MELLON INVESTMENTS Corp0586,641 00Against
ORBIMED ADVISORS LLC500,0000 00For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM432,8830 00For

Institutional-manager reports, all 170 managers: 110,903,489 for, 4,320,537 against, 132,950 abstained, 9,593 not voted. Showing the 25 largest; see all in the interactive database.

4. 2. Ratification of the Company's Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 357,756,707AGAINST: 209,431
Details: description as filed, official tally, votes by 65 asset managers

Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2026;

LifeStance Health Group, Inc.’s own tally for this item (“2. Ratification of the Company's Independent Registered Public Accounting Firm”): 357,756,707 for, 209,431 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ended December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 102,596,277 for, 1 abstained.

FOR
FOR: 102,596,277ABSTAIN: 1
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public acc” at LifeStance Health Group, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity57,010,4840 00For
Vanguard17,528,5950 10For
BlackRock7,390,8800 00For
Prudential/PGIM4,879,8570 00For
Dimensional3,763,1940 00For
TIAA2,179,2450 00For
Charles Schwab1,543,5080 00For
FIRST EAGLE FUNDS1,400,7850 00For
Principal1,159,9300 00For
Putnam828,9000 00For
First Trust792,9770 00For
Equitable368,7520 00For
Goldman Sachs345,2380 00For
State Street304,6390 00For
QUANTITATIVE MASTER SERIES LLC267,9570 00For
Northern Lights Fund Trust IV254,3650 00For
Loomis Sayles239,6150 00For
MERIDIAN FUND INC215,0380 00For
Mercer Funds193,7290 00For
Principal Exchange-Traded Funds191,8920 00For
Lincoln Financial176,9550 00For
Northern Trust141,6310 00For
Global X112,5450 00For
MASTER INVESTMENT PORTFOLIO112,2660 00For
Invesco110,0310 00For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Largest LifeStance Health Group, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 387,813,000 shares outstanding at the time of that meeting.

Fund voting reports: top LifeStance Health Group, Inc. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of the Company's named executive officers;”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 14.70%
2Vanguard 4.52%
3BlackRock 1.91%
4Prudential/PGIM 1.26%
5Dimensional 0.97%
6TIAA 0.56%
7Charles Schwab 0.40%
8FIRST EAGLE FUNDS 0.36%
9Principal 0.30%
10Putnam 0.21%
Institutional-manager reports: top LifeStance Health Group, Inc. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of the Company's named executive officers;”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 15.06%
2JENNISON ASSOCIATES LLC 2.53%
3BlackRock 2.04%
4GEODE CAPITAL MANAGEMENT, LLC 1.22%
5State Street 0.90%
6UBS 0.67%
7Integral Health Asset Management, LLC 0.63%
8Nuveen 0.57%
9PRINCIPAL GLOBAL INVESTORS 0.50%
10Woodline Partners LP 0.46%

Reported LifeStance Health Group, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

LifeStance Health Group, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Parties to the Stockholders Agreement 43.64% DEF14A
TPG VIII Lynnwood Holdings Aggregation, L.P. 36.11% DEF14A
TPG GP A, LLC 25.30% 13G
FMR (Fidelity) 15.13% 13F
FMR, LLC 12.04% DEF14A
Summit Partners and affiliates 7.53% DEF14A
Summit Partners, L.P. 6.01% 13G
BlackRock 4.68% 13F
Vanguard Group 4.56% 13F
Dimensional Fund Advisors 2.67% 13F

Percentages above are of 387,813,000 shares outstanding, as reported by LifeStance Health Group, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LifeStance Health Group, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At LifeStance Health Group, Inc.'s shareholder meeting held June 2, 2026, in the 2025-2026 proxy season, 214 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,175 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the Company's named executive officers; — LifeStance Health Group, Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: LifeStance Health Group, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2026.

LifeStance Health Group, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.